These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 17141623)
1. Fat uses a TOLL-road to connect inflammation and diabetes. Kim JK Cell Metab; 2006 Dec; 4(6):417-9. PubMed ID: 17141623 [TBL] [Abstract][Full Text] [Related]
2. [Physiological and pathological role of adipose tissue innate immune system receptors]. Shvarts V Patol Fiziol Eksp Ter; 2010; (3):45-51. PubMed ID: 20853621 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors, inflammation, metabolism and obesity. Fresno M; Alvarez R; Cuesta N Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616 [TBL] [Abstract][Full Text] [Related]
5. The role of inflammatory cytokines in diabetes and its complications. King GL J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007 [TBL] [Abstract][Full Text] [Related]
8. The c-Jun N-terminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes. Davis JE; Gabler NK; Walker-Daniels J; Spurlock ME Horm Metab Res; 2009 Jul; 41(7):523-30. PubMed ID: 19277946 [TBL] [Abstract][Full Text] [Related]
9. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P; Yeh ET Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046 [TBL] [Abstract][Full Text] [Related]
10. Immunity as a link between obesity and insulin resistance. Kalupahana NS; Moustaid-Moussa N; Claycombe KJ Mol Aspects Med; 2012 Feb; 33(1):26-34. PubMed ID: 22040698 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Suganami T; Mieda T; Itoh M; Shimoda Y; Kamei Y; Ogawa Y Biochem Biophys Res Commun; 2007 Mar; 354(1):45-9. PubMed ID: 17210129 [TBL] [Abstract][Full Text] [Related]
12. [Obesity, inflammation and diabetes]. Miranda-Garduño LM; Reza-Albarrán A Gac Med Mex; 2008; 144(1):39-46. PubMed ID: 18619057 [TBL] [Abstract][Full Text] [Related]
13. miR-107: a toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes. Foley NH; O'Neill LA J Leukoc Biol; 2012 Sep; 92(3):521-7. PubMed ID: 22645244 [TBL] [Abstract][Full Text] [Related]
14. Comment on: Reyna et al. (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57:2595-2602. Shapiro H; Singer P; Attal-Singer J Diabetes; 2009 Apr; 58(4):e5; author reply e6-7. PubMed ID: 19336685 [No Abstract] [Full Text] [Related]